Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-AstraZeneca Diabetes Drug Wins U.S. FDA Approval
Bristol-AstraZeneca Diabetes Drug Wins U.S. FDA Approval
Bristol-AstraZeneca Diabetes Drug Wins U.S. FDA Approval
Submitted by
admin
on January 8, 2014 - 4:20pm
Source:
Bloomberg
News Tags:
Dapagliflozin
FDA
Bristol-Myers Squibb
diabetes
AstraZeneca
Headline:
Bristol-AstraZeneca Diabetes Drug Wins U.S. FDA Approval
Do Not Allow Advertisers to Use My Personal information
